BioMaxima S.A. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was PLN 117.47 million compared to PLN 41.44 million a year ago. Net income was PLN 27.64 million compared to PLN 6.9 million a year ago.

Basic earnings per share from continuing operations was PLN 6.39 compared to PLN 1.6 a year ago. Diluted earnings per share from continuing operations was PLN 6.2 compared to PLN 1.54 a year ago.